Amyloid-β protein precursor family members: A review from homology to biological function

Journal of Alzheimer's Disease

Volumn 26, Issue 4, 2011, Pages 607-626

  Huang, Han Chang ^a,b   Jiang, Zhao Feng ^b  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b BEIJING UNION UNIVERSITY   (China)

Author keywords

Alzheimer's disease; amyloid protein precursor; biological function; homology; structure

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; BIOACCUMULATION; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SENILE PLAQUE; SEQUENCE HOMOLOGY;

EID: 80055039585     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110335     Document Type: Review

References (162)

1. Huang HC, Jiang ZF (2009) Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimers disease. J Alzheimers Dis 16, 15-27.
2. Swanson TL, Knittel LM, Coate TM, Farley SM, Snyder MA, Copenhaver PF (2005) The insect homologue of the amyloid precursor protein interacts with the heterotrimeric G protein Go alpha in an identified population of migratory neurons. Dev Biol 288, 160-178. (Pubitemid 41713161)
3. Fustinana MS, Ariel P, Federman N, Freudenthal R, Romano A (2010) Characterization of the beta amyloid precursor protein-like gene in the central nervous system of the crab Chasmagnathus. Expression during memory consolidation. BMC Neurosci 11, 109.
4. Salbaum JM, Weidemann A, Lemaire HG, Masters CL, Beyreuther K (1988) The promoter of Alzheimers disease amyloid A4 precursor gene. EMBO J 7, 2807-2813.
5. EwaldCY, LiC(2010) Understanding the molecular basis of Alzheimers disease using a Caenorhabditis elegans model system. Brain Struct Funct 214, 263-283.
6. Hornsten A, Lieberthal J, Fadia S, Malins R, Ha L, Xu X, Daigle I, Markowitz M, OConnor G, Plasterk R, Li C (2007) APL-1, a Caenorhabditis elegans protein related to the human beta-amyloid precursor protein, is essential for viability. Proc Natl Acad Sci U S A 104, 1971-1976. (Pubitemid 46239888)
7. Luo LQ, Martin-Morris LE, White K (1990) Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor. J Neurosci 10, 3849-3861.
8. Thinakaran G, Kitt CA, Roskams AJ, Slunt HH, Masliah E, von Koch C, Ginsberg SD, Ronnett GV, Reed RR, Price DL et al. (1995) Distribution of an APP homolog, APLP2, in the mouse olfactory system: a potential role for APLP2 in axogenesis. J Neurosci 15, 6314-6326.
9. Lenkkeri U, Kestila M, Lamerdin J, McCready P, Adamson A, Olsen A, Tryggvason K (1998) Structure of the human amyloid-precursor-like protein gene APLP1 at 19q13.1. Hum Genet 102, 192-196. (Pubitemid 28185242)
10. Thinakaran G, Sisodia SS (1994) Amyloid precursor-like protein 2 (APLP2) is modified by the addition of chondroitin sulfate glycosaminoglycan at a single site. J Biol Chem 269, 22099-22104. (Pubitemid 24282134)
11. Crain BJ, Hu W, Sze CI, Slunt HH, Koo EH, Price DL, Thinakaran G, Sisodia SS (1996) Expression and distribution of amyloid precursor protein-like protein-2 in Alzheimers disease and in normal brain. Am J Pathol 149, 1087-1095. (Pubitemid 26337227)
12. Murakami-Sekimata A, Sato K, Takashima A, Nakano A (2009) O-Mannosylation is required for the solubilization of heterologously expressed human beta-amyloid precursor protein in Saccharomyces cerevisiae. Genes Cells 14, 205-215.
13. Georgopoulou N, McLaughlin M, McFarlane I, Breen KC (2001) The role of post-translational modification in betaamyloid precursor protein processing. Biochem Soc Symp, 23-36. (Pubitemid 33602671)
14. Suzuki T, Nakaya T (2008) Regulation of amyloid betaprotein precursor by phosphorylation and protein interactions. J Biol Chem 283, 29633-29637.
15. Walter J, Haass C (2000) Posttranslational modifications of amyloid precursor protein : ectodomain phosphorylation and sulfation. Methods Mol Med 32, 149-168.
16. Coulson EJ, Paliga K, Beyreuther K, Masters CL (2000) What the evolution of the amyloid protein precursor supergene family tells us about its function. Neurochem Int 36, 175-184. (Pubitemid 30047008)
17. Perdivara I, Petrovich R, Allinquant B, Deterding LJ, Tomer KB, Przybylski M (2009) Elucidation of O-glycosylation structures of the beta-amyloid precursor protein by liquid chromatography-mass spectrometry using electron transfer dissociation and collision induced dissociation. J Proteome Res 8, 631-642.
18. Kaden D, Voigt P, Munter LM, Bobowski KD, Schaefer M, Multhaup G (2009) Subcellular localization and dimerization of APLP1 are strikingly different from APP and APLP2. J Cell Sci 122, 368-377.
19. Asai M, Hattori C, Szabo B, Sasagawa N, Maruyama K, Tanuma S, Ishiura S (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem Biophys Res Commun 301, 231-235. (Pubitemid 36268873)
20. Schmitt U, Hiemke C, Fahrenholz F, Schroeder A (2006) Over-expression of two different forms of the alphasecretase ADAM10 affects learning and memory in mice. Behav Brain Res 175, 278-284. (Pubitemid 44750230)
21. Tanabe C, Hotoda N, Sasagawa N, Sehara-Fujisawa A, Maruyama K, Ishiura S (2007) ADAM19 is tightly associated with constitutive Alzheimers disease APP alphasecretase in A172 cells. Biochem Biophys Res Commun 352, 111-117. (Pubitemid 44821101)
22. Willem M, Lammich S, Haass C (2009) Function, regulation and therapeutic properties of beta-secretase (BACE1). Semin Cell Dev Biol 20, 175-182.
23. Vassar R (2004) BACE1: the beta-secretase enzyme in Alzheimers disease. J Mol Neurosci 23, 105-114.
24. WolfeMS(2008) Gamma-secretase: structure, function, and modulation for Alzheimers disease. Curr Top Med Chem 8, 2-8. (Pubitemid 351791041)
25. Carey RM, Balcz BA, Lopez-Coviella I, Slack BE (2005) Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell Bio 6, 30.
26. Koo EH, Squazzo SL, Selkoe DJ, Koo CH (1996) Trafficking of cell-surface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody. J Cell Sci 109, 991-998.
27. Yamazaki T, Koo EH, Selkoe DJ (1996) Trafficking of cell-surface amyloid beta-protein precursor. II. Endocytosis, recycling and lysosomal targeting detected by immunolocalization. J Cell Sci 109, 999-1008. (Pubitemid 126477168)
28. Pasternak SH, Bagshaw RD, Guiral M, Zhang S, Ackerley CA, Pak BJ, Callahan JW, Mahuran DJ (2003) Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane. J Biol Chem 278, 26687-26694. (Pubitemid 36876814)
29. Zhang YW, Thompson R, Zhang H, Xu H (2011) APP processing in Alzheimers disease. Mol Brain 4, 3.
30. Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, Sisodia SS, Greengard P, Xu H (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci U S A 96, 742-747. (Pubitemid 29061279)
31. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, George-Hyslop PS, Cordell B, Fraser P, De Strooper B (1999) Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 147, 277-294. (Pubitemid 29496338)
32. Eggert S, Paliga K, Soba P, Evin G, Masters CL, Weidemann A, Beyreuther K (2004) The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation. J Biol Chem 279, 18146-18156. (Pubitemid 38623227)
33. Sala Frigerio C, Fadeeva JV, Minogue AM, Citron M, Van Leuven F, Staufenbiel M, Paganetti P, Selkoe DJ, Walsh DM (2010) beta-Secretase cleavage is not required for generation of the intracellular C-terminal domain of the amyloid precursor family of proteins. FEBS J 277, 1503-1518.
34. Jacobsen KT, Adlerz L, Multhaup G, Iverfeldt K (2010) Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein is mediated by different metalloproteinases. J Biol Chem 285, 10223-10231.
35. Jarriault S, Greenwald I (2005) Evidence for functional redundancy between C. elegans ADAM proteins SUP-17/Kuzbanian and ADM-4/TACE. Dev Biol 287, 1-10. (Pubitemid 41587473)
36. Venugopal C, Demos CM, Rao KS, Pappolla MA, Sambamurti K (2008) Beta-secretase: structure, function, and evolution. CNS Neurol Disord Drug Targets 7, 278-294.
37. Ellerbrock BR, Coscarelli EM, Gurney ME, Geary TG (2004) Screening for presenilin inhibitors using the freeliving nematode, Caenorhabditis elegans. J Biomol Screen 9, 147-152.
38. Smialowska A, Baumeister R (2006) Presenilin function in Caenorhabditis elegans. Neurodegener Dis 3, 227-232. (Pubitemid 44600308)
39. Coleman HA, Labrador JP, Chance RK, Bashaw GJ (2010) The Adam family metalloprotease Kuzbanian regulates the cleavage of the roundabout receptor to control axon repulsion at the midline. Development 137, 2417-2426.
40. Udolph G, Rath P, TioM, Toh J, FangW, Pandey R, Technau GM, Chia W (2009) On the roles of Notch, Delta, kuzbanian, and inscuteable during the development of Drosophila embryonic neuroblast lineages. Dev Biol 336, 156-168.
41. Yan Y, Shirakabe K, Werb Z (2002) The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol 158, 221-226.
42. Kotani N, Kitazume S, Kamimura K, Takeo S, Aigaki T, Nakato H, Hashimoto Y (2005) Characterization of Dro sophila aspartic proteases that induce the secretion of a Golgi-resident transferase, heparan sulfate 6-O-sulfotransferase. J Biochem 137, 315-322. (Pubitemid 40628437)
43. Carmine-Simmen K, Proctor T, Tschape J, Poeck B, Triphan T, Strauss R, Kretzschmar D (2009) Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function. Neurobiol Dis 33, 274-281.
44. Urban S, Lee JR, FreemanM(2001) Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases. Cell 107, 173-182. (Pubitemid 33035944)
45. Martoglio B, Golde TE (2003) Intramembrane-cleaving aspartic proteases and disease: presenilins, signal peptide peptidase and their homologs. Hum Mol Genet 12 Spec No 2, R201-R206. (Pubitemid 37259333)
46. Fossgreen A, Bruckner B, Czech C, Masters CL, Beyreuther K, Paro R (1998) Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype. Proc Natl Acad Sci U S A 95, 13703-13708. (Pubitemid 28523036)
47. Sharma S, Prasanthi RPJ, Schommer E, Feist G, Ghribi O (2008) Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol Dis 32, 426-432.
48. Takeuchi Y, Uetsuka K, Murayama M, Kikuta F, Takashima A, Doi K, NakayamaH(2008) Complementary distributions of amyloid-beta and neprilysin in the brains of dogs and cats. Vet Pathol 45, 455-466.
49. Papaioannou N, Tooten PC, van Ederen AM, Bohl JR, Rofina J, Tsangaris T, Gruys E (2001) Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 8, 11-21. (Pubitemid 32210176)
50. Cork LC, Masters C, Beyreuther K, Price DL (1990) Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits. Am J Pathol 137, 1383-1392.
51. Gearing M, Tigges J, Mori H, Mirra SS (1997) beta-Amyloid (A beta) deposition in the brains of aged orangutans. Neurobiol Aging 18, 139-146. (Pubitemid 27355931)
52. Jacobsen KT, Iverfeldt K (2009) Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors. Cell Mol Life Sci 66, 2299-2318.
53. Hoopes JT, Liu X, Xu X, Demeler B, Folta-Stogniew E, Li C, Ha Y (2010) Structural characterization of the E2 domain of APL-1, a Caenorhabditis elegans homolog of human amyloid precursor protein, and its heparin binding site. J Biol Chem 285, 2165-2173.
54. Dahms SO, Hoefgen S, Roeser D, Schlott B, Guhrs KH, Than ME (2010) Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein. Proc Natl Acad Sci U S A 107, 5381-5386.
55. Wang Y, Ha Y (2004) The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain. Mol Cell 15, 343-353. (Pubitemid 39092751)
56. Clarris HJ, Cappai R, Heffernan D, Beyreuther K, Masters CL, Small DH (1997) Identification of heparin-binding domains in the amyloid precursor protein of Alzheimers disease by deletion mutagenesis and peptide mapping. J Neurochem 68, 1164-1172. (Pubitemid 27086222)
57. Crescenzi O, Tomaselli S, Guerrini R, Salvadori S, DUrsi AM, Temussi PA, Picone D (2002) Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. Eur J Biochem 269, 5642-5648. (Pubitemid 35365553)
58. Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A (2011) Functional interactions of fibrillar and oligomeric amyloid-beta with alpha7 nicotinic receptors in Alzheimers disease. J Alzheimers Dis 23, 335-347.
59. Fa M, Orozco IJ, Francis YI, Saeed F, Gong Y, Arancio O (2011) Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices. J Vis Exp 41, pii: 1884. doi: 10.3791/1884.
60. Sachse C, Fandrich M, Grigorieff N (2008) Paired betasheet structure of an Abeta(1-40) amyloid fibril revealed by electron microscopy. Proc Natl Acad Sci U S A 105, 7462-7466. (Pubitemid 351830040)
61. Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H, Schubert D, Riek R (2005) 3D structure of Alzheimers amyloid-beta(1-42) fibrils. Proc Natl Acad Sci U S A 102, 17342-17347.
62. Dahse K, Garvey M, Kovermann M, Vogel A, Balbach J, Fandrich M, Fahr A (2010) DHPC strongly affects the structure and oligomerization propensity of Alzheimers Abeta(1-40) peptide. J Mol Biol 403, 643-659.
63. Cerpa W, Dinamarca MC, Inestrosa NC (2008) Structurefunction implications in Alzheimers disease: effect of Abeta oligomers at central synapses. Curr Alzheimer Res 5, 233-243. (Pubitemid 351840275)
64. Kroenke CD, Ziemnicka-Kotula D, Xu J, Kotula L, Palmer AG, 3rd (1997) Solution conformations of a peptide containing the cytoplasmic domain sequence of the beta amyloid precursor protein. Biochemistry 36, 8145-8152. (Pubitemid 27284192)
65. Ramelot TA, Gentile LN, Nicholson LK (2000) Transient structure of the amyloid precursor protein cytoplasmic tail indicates preordering of structure for binding to cytosolic factors. Biochemistry 39, 2714-2725. (Pubitemid 30148926)
66. Reinhard C, Hebert SS, De Strooper B (2005) The amyloidbeta precursor protein: integrating structure with biological function. EMBO J 24, 3996-4006. (Pubitemid 41752869)
67. Tamayev R, Zhou D, DAdamio L (2009) The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains. Mol Neurodegener 4, 28.
68. Tarr PE, Roncarati R, Pelicci G, Pelicci PG, DAdamio L (2002) Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J Biol Chem 277, 16798-16804. (Pubitemid 34967702)
69. Barbagallo AP, Wang Z, Zheng H, DAdamio L (2011) A single tyrosine residue in the amyloid precursor protein intracellular domain is essential for developmental function. J Biol Chem 286, 8717-8721.
70. Radzimanowski J, Simon B, Sattler M, Beyreuther K, Sinning I, Wild K (2008) Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65-PTB2. EMBO Rep 9, 1134-1140.
71. Li H, Koshiba S, Hayashi F, Tochio N, Tomizawa T, Kasai T, Yabuki T, Motoda Y, Harada T, Watanabe S, Inoue M, Hayashizaki Y, Tanaka A, Kigawa T, Yokoyama S (2008) Structure of the C-terminal phosphotyrosine interaction domain of Fe65L1 complexed with the cytoplasmic tail of amyloid precursor protein reveals a novel peptide binding mode. J Biol Chem 283, 27165-27178.
72. Tanahashi H, Tabira T (2002) Characterization of an amyloid precursor protein-binding protein Fe65L2 and its novel isoforms lacking phosphotyrosine-interaction domains. Biochem J 367, 687-695. (Pubitemid 35305707)
73. Beyer AS, von Einem B, Schwanzar D, Keller IE, Hellrung A, Thal DR, Ingelsson M, Makarova A, Deng M, Chhabra ES, Propper C, Bockers TM, Hyman BT, von Arnim CA (2010) Engulfment adapter PTB domain containing 1 interacts with and affects processing of the amyloid-beta precursor protein. Neurobiol Aging. doi:10.1016/j.neuro biolaging.2010.06.006
74. Borg JP, Ooi J, Levy E, Margolis B (1996) The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16, 6229-6241. (Pubitemid 26360983)
75. Homayouni R, Rice DS, Sheldon M, Curran T (1999) Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1. J Neurosci 19, 7507-7515. (Pubitemid 29404607)
76. Kyriazis GA, Wei Z, Vandermey M, Jo DG, Xin O, Mattson MP, Chan SL (2008) Numb endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner: implications for Alzheimer disease pathogenesis. J Biol Chem 283, 25492-25502.
77. Young-Pearse TL, Suth S, Luth ES, Sawa A, Selkoe DJ (2010) Biochemical and functional interaction of disruptedin-schizophrenia 1 and amyloid precursor protein regulates neuronal migration during mammalian cortical development. J Neurosci 30, 10431-10440.
78. Perreau VM, Orchard S, Adlard PA, Bellingham SA, Cappai R, Ciccotosto GD, Cowie TF, Crouch PJ, Duce JA, Evin G, Faux NG, Hill AF, Hung YH, James SA, Li QX, Mok SS, Tew DJ, White AR, Bush AI, Hermjakob H, Masters CL (2010) A domain level interaction network of amyloid precursor protein and Abeta of Alzheimers disease. Proteomics 10, 2377-2395.
79. Walsh DM, Minogue AM, Sala Frigerio C, Fadeeva JV, Wasco W, Selkoe DJ (2007) The APP family of proteins: similarities and differences. Biochem Soc Trans 35, 416-420. (Pubitemid 46596519)
80. Chial HJ, Lenart P, Chen YQ (2010) APPL proteins FRET at the BAR: direct observation of APPL1 and APPL2 BAR domain-mediated interactions on cell membranes using FRET microscopy. PLoS One 5, e12471.
81. Smith RP, Higuchi DA, Broze GJ, Jr (1990) Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science 248, 1126-1128.
82. Van Nostrand WE, Wagner SL, Farrow JS, Cunningham DD (1990) Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor. J Biol Chem 265, 9591-9594.
83. Salameh MA, Robinson JL, Navaneetham D, Sinha D, Madden BJ, Walsh PN, Radisky ES (2010) The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin. J Biol Chem 285, 1939-1949.
84. Schubert D, Behl C (1993) The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix. Brain Res 629, 275-282. (Pubitemid 23337802)
85. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10, 243-254. (Pubitemid 23079546)
86. Gralle M, Ferreira ST (2007) Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol 82, 11-32. (Pubitemid 46719589)
87. Wiese M, Antebi A, ZhengH(2010) Intracellular trafficking and synaptic function of APL-1 in Caenorhabditis elegans. PLoS One 5, pii: e12790
88. Torroja L, Packard M, Gorczyca M, White K, Budnik V (1999) The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J Neurosci 19, 7793-7803. (Pubitemid 30225778)
89. Leyssen M, Ayaz D, Hebert SS, Reeve S, De Strooper B, Hassan BA (2005) Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain. EMBO J 24, 2944-2955. (Pubitemid 43079897)
90. Goguel V, Belair AL, Ayaz D, Lampin-Saint-Amaux A, Scaplehorn N, Hassan BA, Preat T (2011) Drosophila amyloid precursor protein-like is required for long-term memory. J Neurosci 31, 1032-1037.
91. Zheng H, Jiang M, Trumbauer ME, Hopkins R, Sirinathsinghji DJ, Stevens KA, Conner MW, Slunt HH, Sisodia SS, Chen HY, Van der Ploeg LH (1996) Mice deficient for the amyloid precursor protein gene. Ann N Y Acad Sci 777, 421-426. (Pubitemid 26149224)
92. Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, Rulicke T, von Kretzschmar H, von Koch C, Sisodia S, Tremml P, Lipp HP, Wolfer DP, Muller U (2000) Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci 20, 7951-7963.
93. von Koch CS, Zheng H, Chen H, Trumbauer M, Thinakaran G, van der Ploeg LH, Price DL, Sisodia SS (1997) Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol Aging 18, 661-669. (Pubitemid 28046419)
94. Aydin D, Filippov MA, Tschape JA, Gretz N, Prinz M, Eils R, Brors B, Muller UC (2011) Comparative transcriptome profiling of amyloid precursor protein family members in the adult cortex. BMC Genomic 12, 160.
95. Anliker B, Muller U (2006) The functions of mammalian amyloid precursor protein and related amyloid precursorlike proteins. Neurodegener Dis 3, 239-246. (Pubitemid 44600310)
96. Ring S, Weyer SW, Kilian SB, Waldron E, Pietrzik CU, Filippov MA, Herms J, Buchholz C, Eckman CB, Korte M, Wolfer DP, Muller UC (2007) The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J Neurosci 27, 7817-7826. (Pubitemid 47093823)
97. Soba P, Eggert S, Wagner K, Zentgraf H, Siehl K, Kreger S, Lower A, Langer A, Merdes G, Paro R, Masters CL, Muller U, Kins S, Beyreuther K (2005) Homo-and heterodimerization of APP family members promotes intercellular adhesion. EMBO J 24, 3624-3634. (Pubitemid 41509369)
98. Richter L, Munter LM, Ness J, Hildebrand PW, Dasari M, Unterreitmeier S, Bulic B, Beyermann M, Gust R, Reif B, Weggen S, Langosch D, Multhaup G (2010) Amyloid beta peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization. Proc Natl Acad Sci U S A 107, 14597-14602.
99. Munter LM, Botev A, Richter L, Hildebrand PW, Althoff V, Weise C, Kaden D, Multhaup G (2010) Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. J Biol Chem 285, 21636-21643.
100. Eggert S, Midthune B, Cottrell B, Koo EH (2009) Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production. J Biol Chem 284, 28943-28952.
101. Xu F, Previti ML, Nieman MT, Davis J, Schmaier AH, Van NostrandWE(2009) AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis. J Neurosci 29, 5666-5670.
102. Nikolaev A, McLaughlin T, OLeary DD, Tessier-Lavigne M(2009)APPbindsDR6to trigger axon pruning and neuron death via distinct caspases. Nature 457, 981-989.
103. Galbete JL, Martin TR, Peressini E, Modena P, Bianchi R, Forloni G (2000) Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. Biochem J 348 Pt 2, 307-313. (Pubitemid 30345202)
104. Liu C, Rozmyslowicz T, Stwora-Wojczyk M, Wojczyk B, Spitalnik SL (2000) Posttranslational modifications of the amyloid precursor protein : glycosylation. Methods Mol Med 32, 169-190.
105. Ullrich S, Munch A, Neumann S, Kremmer E, Tatzelt J, Lichtenthaler SF (2010) The novel membrane protein TMEM59 modulates complex glycosylation, cell surface expression, and secretion of the amyloid precursor protein. J Biol Chem 285, 20664-20674.
106. Gralle M, Oliveira CL, Guerreiro LH, McKinstry WJ, Galatis D, Masters CL, Cappai R, Parker MW, Ramos CH, Torriani I, Ferreira ST (2006) Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor protein. J Mol Biol 357, 493-508. (Pubitemid 43290750)
107. McKeon J, Holland LA (2004) Determination of dissociation constants for a heparin-binding domain of amyloid precursor protein and heparins or heparan sulfate by affinity capillary electrophoresis. Electrophoresis 25, 1243-1248. (Pubitemid 38801640)
108. Multhaup G, Mechler H, Masters CL (1995) Characterization of the high affinity heparin binding site of the Alzheimers disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II). J Mol Recognit 8, 247-257.
109. Corrigan F, Pham CL, Vink R, Blumbergs PC, Masters CL, van den Heuvel C, Cappai R (2011) The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Res 1378, 137-143.
110. Small DH, Nurcombe V, Reed G, Clarris H, Moir R, Beyreuther K, Masters CL (1994) A heparin-binding domain in the amyloid protein precursor of Alzheimers disease is involved in the regulation of neurite outgrowth. J Neurosci 14, 2117-2127. (Pubitemid 24108121)
111. Leveugle B, Ding W, Durkin JT, Mistretta S, Eisle J, Matic M, Siman R, Greenberg BD, Fillit HM (1997) Heparin promotes beta-secretase cleavage of the Alzheimers amyloid precursor protein. Neurochem Int 30, 543-548. (Pubitemid 27187224)
112. Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL, Beyreuther K (1996) The amyloid precursor protein of Alzheimers disease in the reduction of copper(II) to copper(I). Science 271, 1406-1409. (Pubitemid 26089474)
113. Lin CJ, Huang HC, Jiang ZF (2010) Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains. Brain Res Bull 82, 235-242.
114. Suazo M, Hodar C, Morgan C, Cerpa W, Cambiazo V, Inestrosa NC, Gonzalez M (2009) Overexpression of amyloid precursor protein increases copper content in HEK293 cells. Biochem Biophys Res Commun 382, 740-744.
115. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimers disease. Cell 142, 857-867.
116. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimers disease senile plaques. J Neurol Sci 158, 47-52. (Pubitemid 28277534)
117. Muller T, Meyer HE, Egensperger R, Marcus K (2008) The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimers disease. Prog Neurobiol 85, 393-406.
118. Muller T, Concannon CG, Ward MW, Walsh CM, Tirniceriu AL, Tribl F, Kogel D, Prehn JH, Egensperger R (2007) Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell 18, 201-210. (Pubitemid 46066721)
119. Ma H, Lesne S, Kotilinek L, Steidl-Nichols JV, Sherman M, Younkin L, Younkin S, Forster C, Sergeant N, Delacourte A, Vassar R, Citron M, Kofuji P, Boland LM, Ashe KH (2007) Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. Proc Natl Acad Sci U S A 104, 8167-8172. (Pubitemid 47185893)
120. Wang H, Song L, Laird F, Wong PC, Lee HK (2008) BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J Neurosci 28, 8677-8681.
121. von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, Konietzko U (2004) The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci 117, 4435-4448. (Pubitemid 39360070)
122. Raychaudhuri M, Mukhopadhyay D (2010) AICD Overexpression in Neuro 2A Cells Regulates Expression of PTCH1 and TRPC5. Int J Alzheimers Dis 2011, pii: 239453.
123. Takahashi K, Niidome T, Akaike A, Kihara T, Sugimoto H (2008) Phosphorylation of amyloid precursor protein (APP) at Tyr687 regulates APP processing by alpha-and gammasecretase. Biochem Biophys Res Commun 377, 544-549.
124. Theuns J, Brouwers N, Engelborghs S, Sleegers K, Bogaerts V, Corsmit E, De Pooter T, van Duijn CM, De Deyn PP, Van Broeckhoven C (2006) Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet 78, 936-946. (Pubitemid 43787686)
125. Kwok JB, Li QX, Hallupp M, Whyte S, Ames D, Beyreuther K, Masters CL, Schofield PR (2000) Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis. Ann Neurol 47, 249-253. (Pubitemid 30078575)
126. Ghidoni R, Paterlini A, Albertini V, Glionna M, Monti E, Schiaffonati L, Benussi L, Levy E, Binetti G (2009) Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimers disease. Neurobiol Aging, doi:10.1016/j.neuro biolaging.2009.08.013.
127. Murrell JR, Hake AM, Quaid KA, Farlow MR, Ghetti B (2000) Early-onset Alzheimer disease caused by a new mutation (V717 L) in the amyloid precursor protein gene. Arch Neurol 57, 885-887. (Pubitemid 30397192)
128. Godbolt AK, Beck JA, Collinge JC, Cipolotti L, Fox NC, Rossor MN (2006) A second family with familial AD and the V717 L APP mutation has a later age at onset. Neurology 66, 611-612. (Pubitemid 43739907)
129. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimers disease. Science 254, 97-99. (Pubitemid 21917324)
130. Finckh U, Kuschel C, Anagnostouli M, Patsouris E, Pantes GV, Gatzonis S, Kapaki E, Davaki P, Lamszus K, Stavrou D, Gal A (2005) Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics 6, 85-89. (Pubitemid 40768119)
131. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J et al. (1991) Early-onset Alzheimers disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353, 844-846. (Pubitemid 21912637)
132. Talarico G, Piscopo P, Gasparini M, Salati E, Pignatelli M, Pietracupa S, Malvezzi-Campeggi L, Crestini A, Boschi S, Lenzi GL, Confaloni A, Bruno G (2010) The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with earlyonset Alzheimers disease. Dement Geriatr Cogn Disord 29, 484-490.
133. Eckman CB, Mehta ND, Crook R, Perez-tur J, Prihar G, Pfeiffer E, Graff-Radford N, Hinder P, Yager D, Zenk B, Refolo LM, Prada CM, Younkin SG, Hutton M, Hardy J (1997)Anewpathogenic mutation in the APP gene (I716 V) increases the relative proportion of A beta 42(43). Hum Mol Genet 6, 2087-2089. (Pubitemid 27477950)
134. Guerreiro RJ, Baquero M, Blesa R, Boada M, Bras JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, Gomez-Isla T, Hernandez I, Lleo A, Machado A, Martinez-Lage P, Masdeu J, Molina-Porcel L, Molinuevo JL, Pastor P, Perez-Tur J,
135. Forloni G, Terreni L, Bertani I, Fogliarino S, Invernizzi R, Assini A, Ribizzi G, Negro A, Calabrese E, Volonte MA, Mariani C, Franceschi M, Tabaton M, Bertoli A (2002) Protein misfolding in Alzheimers and Parkinsons disease: genetics and molecular mechanisms. Neurobiol Aging 23, 957-976. (Pubitemid 35217718)
136. Ancolio K, Dumanchin C, Barelli H, Warter JM, Brice A, Campion D, Frebourg T, Checler F (1999) Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 Met betaAPP-770 mutation responsible for probable early-onset Alzheimers disease. Proc Natl Acad Sci U S A 96, 4119-4124. (Pubitemid 29169046)
137. De Jonghe C, Esselens C, Kumar-Singh S, Craessaerts K, Serneels S, Checler F, Annaert W, Van Broeckhoven C, De Strooper B (2001) Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum Mol Genet 10, 1665-1671. (Pubitemid 32776296)
138. Roks G, Van Harskamp F, De Koning I, Cruts M, De Jonghe C, Kumar-Singh S, Tibben A, Tanghe H, Niermeijer MF, Hofman A, Van Swieten JC, Van Broeckhoven C, Van Duijn CM (2000) Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain 123, 2130-2140.
139. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D (2006) APP locus duplication causes autosomal dominant earlyonset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38, 24-26. (Pubitemid 43011878)
140. Pasalar P, Najmabadi H, Noorian AR, Moghimi B, Jannati A, Soltanzadeh A, Krefft T, Crook R, Hardy J (2002) An Iranian family with Alzheimers disease caused by a novel APP mutation (Thr714Ala). Neurology 58, 1574-1575. (Pubitemid 34552978)
141. Carter DA, Desmarais E, Bellis M, Campion D, Clerget-Darpoux F, Brice A, Agid Y, Jaillard-Serradt A, Mallet J (1992) More missense in amyloid gene. Nat Genet 2, 255-256.
142. Bernardi L, Geracitano S, Colao R, Puccio G, Gallo M, Anfossi M, Frangipane F, Curcio SA, Mirabelli M, Tomaino C, Vasso F, Smirne N, Maletta R, Bruni AC (2009) AbetaPP A713T mutation in late onset Alzheimers disease with cerebrovascular lesions. J Alzheimers Dis 17, 383-389.
143. Jones CT, Morris S, Yates CM, Moffoot A, Sharpe C, Brock DJ, St Clair D (1992) Mutation in codon 713 of the beta amyloid precursor protein gene presenting with schizophrenia. Nat Genet 1, 306-309.
144. Obici L, Demarchi A, de Rosa G, Bellotti V, Marciano S, Donadei S, Arbustini E, Palladini G, Diegoli M, Genovese E, Ferrari G, Coverlizza S, Merlini G (2005) A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann Neurol 58, 639-644. (Pubitemid 41377231)
145. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49, 697-705. (Pubitemid 32530235)
146. Greenberg SM, Shin Y, Grabowski TJ, Cooper GE, Rebeck GW, Iglesias S, Chapon F, Tournier-Lasserve E, Baron JC (2003) Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation. Neurology 60, 1020-1022. (Pubitemid 36348940)
147. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, LuyendijkW, FrangioneB( 1990) Mutation of the Alzheimers disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126.
148. Salmona M, Malesani P, De Gioia L, Gorla S, Bruschi M, Molinari A, Della Vedova F, Pedrotti B, Marrari MA, Awan T, Bugiani O, Forloni G, Tagliavini F (1999) Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. Biochem J 342, 207-214. (Pubitemid 29410867)
149. Bugiani O, Giaccone G, Rossi G, Mangieri M, Capobianco R, Morbin M, Mazzoleni G, Cupidi C, Marcon G, Giovagnoli A, Bizzi A, Di Fede G, Puoti G, Carella F, Salmaggi A, Romorini A, Patruno GM, Magoni M, Padovani A, Tagliavini F (2010) Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol 67, 987-995.
150. Kamino K, Orr HT, Payami H, Wijsman EM, Alonso ME, Pulst SM, Anderson L, ODahl S, Nemens E, White JA et al (1992) Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 51, 998-1014.
151. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Naslund J, Lannfelt L (2001) The Arctic APP mutation (E693 G) causes Alzheimers disease by enhanced Abeta protofibril formation. Nat Neurosci 4, 887-893. (Pubitemid 32801591)
152. Takuma H, Teraoka R, Mori H, Tomiyama T (2008) Amyloid-beta E22Delta variant induces synaptic alteration in mouse hippocampal slices. Neuroreport 19, 615-619. (Pubitemid 351489355)
153. Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin JJ et al (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1, 218-221.
154. Kumar-Singh S, Julliams A, Nuydens R, Ceuterick C, Labeur C, Serneels S, Vennekens K, Van Osta P, Geerts H, De Strooper B, Van Broeckhoven C (2002) In vitro studies of Flemish, Dutch, and wild-type beta-amyloid provide evidence for two-staged neurotoxicity. Neurobiol Dis 11, 330-340. (Pubitemid 36135696)
155. Brouwers N, Sleegers K, Van Broeckhoven C (2008) Molecular genetics of Alzheimers disease: an update. Ann Med 40, 562-583.
156. Wakutani Y, Watanabe K, Adachi Y, Wada-Isoe K, Urakami K, Ninomiya H, Saido TC, Hashimoto T, Iwatsubo T, Nakashima K (2004) Novel amyloid precursor protein gene missense mutation (D678 N) in probable familial Alzheimers disease. J Neurol Neurosurg Psychiatry 75, 1039-1042. (Pubitemid 38869622)
157. Wakutani Y (2005) Gene symbol: APP. Disease: Familial Alzheimers disease. Hum Gene 117, 299.
158. Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J (2003) Early onset familial Alzheimers disease: Mutation frequency in families. Neurology 60, 235-239. (Pubitemid 36152015)
159. Di Fede G, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G, Merlin M, Giovagnoli AR, Prioni S, Erbetta A, Falcone C, Gobbi M, Colombo L, Bastone A, Beeg M, Manzoni C, Francescucci B, Spagnoli A, Cantu L, Del Favero E, Levy E, Salmona M, Tagliavini F (2009) A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323, 1473-1477.
160. Giaccone G, Morbin M, Moda F, Botta M, Mazzoleni G, Uggetti A, Catania M, Moro ML, Redaelli V, Spagnoli A, Rossi RS, Salmona M, Di Fede G, Tagliavini F (2010) Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features. Acta Neuropathol 120, 803-812.
161. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimers disease in the APP gene at the Nterminus of beta-amyloid. Nat Genet 1, 345-347.
162. Peacock ML, Murman DL, Sima AA, Warren JT, Jr., Roses AD, Fink JK (1994) Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimers disease. Ann Neurol 35, 432-438.